Zyngenia Competitors and Similar CompaniesClear all

Zyngenia's competitors and similar companies include G1 Therapeutics, Reglagene, Arrakis Therapeutics and ROPHIBIO.
Zyngenia
Zyngenia
Zyngenia is a company developing biotherapeutics that simultaneously target multiple physiologic pathways.
G1 Therapeutics
G1 Therapeutics
G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.
Reglagene
Reglagene
Reglagene is a company that discovers and develops noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment.
Arrakis Therapeutics
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical company which offers a drug discovery platform intended to target RNA.
ROPHIBIO
ROPHIBIO
ROPHIBIO is a company developing protein/antibody, gene/cell, and stem cell therapeutics.
Founding Date
Founding Date
2009
Founding Date
2008
Founding Date
2016
Founding Date
2015
Founding Date
2007
Type
Type
Private
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Washington, US HQ
Locations
Durham, US HQ
Locations
Tucson, US HQ
Locations
Waltham, US HQ
Waltham, US
Locations
Cheongwon-gun, KR HQ
Gaithersburg, US
Employees
Employees
N/A
Employees
17015% increase
Employees
14
Employees
84
Employees
N/A

Funding

Latest funding round
Latest funding round
$ 25m (over 15 years ago)
Latest funding round
N/A
Latest funding round
$ 546.4k (almost 8 years ago)
Latest funding round
$ 75m (about 7 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 25m
Total funding raised
$ 289.6m
Total funding raised
$ 546.4k
Total funding raised
$ 113m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

G1 Therapeutics
HQ
Durham, US
Employees
170↑ 15% increase

G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer.

View company
Reglagene
HQ
Tucson, US
Employees
14

Reglagene is a company that discovers and develops noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment.

View company
Arrakis Therapeutics
HQ
Waltham, US
Employees
84

Arrakis Therapeutics is a biopharmaceutical company which offers a drug discovery platform intended to target RNA.

View company
ROPHIBIO
HQ
Cheongwon-gun, KR

ROPHIBIO is a company developing protein/antibody, gene/cell, and stem cell therapeutics.

View company